default author photo

Daniele Generali

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

2

DOWNLOADS

112

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Integrating Computational Prognosis with Diagnostic Imaging in Breast Cancer: A Proof-of-Concept Case Report Study

Number of pages: 41 Posted: 30 Jan 2025
Gianpaolo Ruocco, Graziella Graziella Marino, Maria Valeria De Bonis, Marisabel Mecca, Aldo Cammarota, Manuela Botte, Giuseppina Dinardo, Maria Imma Lancellotti, Antonio Villonio, Antonella Prudente, Alexios Thodas, Francesca Sanseverino, Francesco Schettini, Andrea Rocca, Daniele Generali and Emanuela Zifarone
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Universidad de Barcelona - Hospital Clínic Barcelona, University of Trieste, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 60 (961,006)

Abstract:

Loading...

Breast Cancer, neoadjuvant therapy, Mass transfer, reactive-diffusive modeling, multidimensional modeling, computational prognosis

2.

Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2

Number of pages: 34 Posted: 12 Sep 2025
Giacomo Mazzoli, Leonardo Provenzano, Maria Vittoria Dieci, Giuseppe Curigliano, Mario Giuliano, Andrea Botticelli, Matteo Lambertini, Rizzo Gianpiero, Rebecca Pedersini, Marianna Sirico, Nicla La Verde, Alessandra Gennari, Alberto Zambelli, Angela Toss, Marta Piras, Monica Giordano, Barbara Tagliaferri, Daniele Generali, Donata Sartori, Giuseppe Fotia, Matteo De Monte, Francesca Ligorio and Flavia Jacobs
Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Università di Padova - Dipartimento di Scienze Chirurgiche, European Institute of Oncology (IEO) IRCCS - Division of New Drugs and Early Drug Development for Innovative Therapies, Baylor College of Medicine, Sapienza University of Rome, University of Genova - Department of Internal Medicine and Medical Specialties (DiMI), Fondazione IRCCS Policlinico San Matteo, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, ASST Papa Giovanni XXIII, affiliation not provided to SSRN, Università Vita-Salute San Raffaele - IRCCS Ospedale San Raffaele, Azienda Socio Sanitaria Territoriale Lariana, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori and Fondazione IRCCS Istituto Nazionale dei Tumori
Downloads 52 (1,041,696)

Abstract:

Loading...

HR+/HER2- advanced breast cancer, CDK4/6 inhibitors, Real-world, progression-free survival, Lobular histology, PALMARES-2